| A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer | |
| Cheng, Ying; Wang, Xingkai; Xia, Xiangying; Zhang, Wei; Tian, Hongqi | |
| 2019 | |
| 卷号 | 145期号:2页码:586-596 |
| 关键词 | benzoxazole compound MEK inhibitor RAF RAS mutant cancer synergism high potency |
| ISSN号 | 0020-7136 |
| DOI | 10.1002/ijc.32119 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6345605 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Cheng, Ying,Wang, Xingkai,Xia, Xiangying,et al. A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer[J],2019,145(2):586-596. |
| APA | Cheng, Ying,Wang, Xingkai,Xia, Xiangying,Zhang, Wei,&Tian, Hongqi.(2019).A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer.,145(2),586-596. |
| MLA | Cheng, Ying,et al."A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer".145.2(2019):586-596. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论